USPTO issues two new patents to Cellectis for TAL-effector nuclease
In Minnesota, Cellectis, a genome engineering specialist, announced the issuance by the USPTO on May 14th, 2013 of two new US patents (US 8,440,431 and US 8,440,432) directed to TAL-effector nucleases. The molecules produced by Cellectis have been distributed to prestigious laboratories over the world under the trademark TALEN.
The inventors of both patents are Pr. Daniel Voytas, from the University of Minnesota, Dr. Adam Bogdanove from the Iowa State University and Dr. Feng Zhang who serves as Chief Operating Officer of Cellectis Plant Sciences in New Brighton, a subsidiary dedicated to applying sequence-specific nucleases in plants for agricultural biotechnology applications. Pr. Daniel Voytas is also the Chief Scientific Officer of Cellectis Plant Sciences.
Category: Dashboard
